Biomarkers in Liquid Biopsies for Prediction of Early Liver Metastases in Pancreatic Cancer

Biomarkers in Liquid Biopsies for Prediction of Early Liver Metastases in Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive solid malignancies with poor survival rates. Only 20% of the patients are eligible for R0-surgical resection, presenting with early relapses, mainly in the liver. PDAC patients with hepatic metastases have a worse outcome compared...

Full description

Bibliographic Details
Main Authors: Anne-Sophie Mehdorn, Timo Gemoll, Hauke Busch, Katharina Kern, Silje Beckinger, Tina Daunke, Christoph Kahlert, Faik G. Uzunoglu, Alexander Hendricks, Florian Buertin, Uwe A. Wittel, Yoshiaki Sunami, Christoph Röcken, Thomas Becker, Susanne Sebens
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Cancers
Subjects:
pancreatic ductal adenocarcinoma
PDAC
hepatic metastasis
multiplex analysis
Olink<sup>®</sup>
LEGENDplex<sup>TM</sup>
Online Access:https://www.mdpi.com/2072-6694/14/19/4605

Internet

https://www.mdpi.com/2072-6694/14/19/4605

Similar Items